Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (FARN.L) Stock Overview
Explore Faron Pharmaceuticals Oy’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
218.3M
P/E Ratio
-7649.12
EPS (TTM)
$-0.25
ROE
0.01%
FARN.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Faron Pharmaceuticals Oy (FARN.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 44.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $140.97.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7649.12 and a market capitalization of 218.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.